Marengo Asia Hospitals
Faridabad, Haryana, 121002, India
Location status: Recruiting
Location contact
Bharat Nair, MBBS, MS, MRCS, MCh
CONTACT
Bharat Nair, MBBS, MS, MRCS, MCh
PRINCIPAL_INVESTIGATOR
Priyanka Tripathi
CONTACT
NCT Number: NCT06769776
Prophylactic abdominal drain placement after donor hepatectomy has been a common or even mandatory practice in most transplant centers. This serves to monitor the occurrence of post-operative intra-abdominal bleeding and is used for the detection and drainage of any bile leakage. However prophylactic drain placement is not without complications, like; Increased rates of intraabdominal and wound infection, Increased abdominal pain, Decreased pulmonary function, Bowel injury and Prolonged hospital stay. Comprehensive Complication Index (CCI) is a valuable tool used to assess the overall morbidity of patients after surgical interventions . The CCI score ranges from 0 (no complication) to 100 (death), reflecting the gravity of the overall complication burden on the patient on a continuous scale and is a validated tool for living donor liver transplants. The investigators aim to compare the safety of no drain placement vs abdominal drain placement in LDLT(Live Donor Liver Transplant) by comparing the comprehensive complication index(CCI) between both arms at day of discharge after donor hepatectomy.
Interested in participating?
Request Info18 year–55 year
All sexes
Interventional
Not applicable
Faridabad, Haryana, 121002, India
Location status: Recruiting
Bharat Nair, MBBS, MS, MRCS, MCh
CONTACT
Bharat Nair, MBBS, MS, MRCS, MCh
PRINCIPAL_INVESTIGATOR
Priyanka Tripathi
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients undergoing donor hepatectomy -
Exclusion criteria
Any patient not consenting to the procedure. Intraoperative need for drain placement in no drain arm due to surgical factors.
Inverted L/ J shaped incision. Laparoscopic donor hepatectomy Robotic donor hepatectomy.
-
Omission of abdominal drain placement in intervention arm. The No-drain arm will be compared to drain arm
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7.
Comprehensive Complication Index (CCI) is a valuable tool used to assess the overall morbidity of patients after surgical interventions . The CCI score ranges from 0 (no complication) to 100 (death), reflecting the gravity of the overall complication burden on the patient on a continuous scale and is a validated tool for living donor liver transplants. The investigators aim to compare the safety of no drain placement vs abdominal drain placement in LDLT by comparing the comprehensive complication index(CCI) between both arms on post operative day 7 after donor hepatectomy.
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7
Surgical site infections, intra abdominal abscesses
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7
Total days of hospitalization required from admission till post operative day 7
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7.
Days to start normal oral diet after surgery
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7
Occurrence and detection of bile leak after donor hepatectomy
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7
Occurrence and detection of bleeding after live donor hepatectomy
Time frame: Admission one day prior to live donor hepatectomy till post operative day 7
Post operative pain as measured by twice daily (Visual Analogue Scale)VAS scores
Contact information is provided by the study sponsor or research team.
Bharat Nair, MCh
CONTACT
Priyanka Tripathi
CONTACT
Marengo Asia Hospitals
Other
Drain Versus No-Drain After Live Donor Hepatectomy- A Randomized Controlled, Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715500
Chronic Liver Disease and Cirrhosis, Donor Hepatectomy
New Delhi, India
View Trial DetailsNCT07723391
Donor Hepatectomy, Glucose Metabolism Disorders
Islamabad, Federal, Pakistan
View Trial DetailsNCT04733547
Central Venous Catheter, Donor Hepatectomy
Daegu, South Korea
View Trial DetailsNCT02531529
Donor Hepatectomy
Al Mansurah, Dkahleya, Egypt
View Trial Details